Atlas Trials

A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD

Clinical trial NCT01242254 · COMPLETED

Trial details

NCT number
NCT01242254
Sponsor
Chengdu Kanghong Biotech Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neovascular Age-related Macular Degeneration
Start date
2009-08-01
Primary completion
2010-03-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.